Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CHEMOCENTRYX, INC.

(CCXI)
Delayed Nasdaq  -  04:00 2022-10-19 pm EDT
51.99 USD   +0.06%
10/24ChemoCentryx, Inc.(NasdaqGS:CCXI) dropped from S&P Global BMI Index
CI
10/24ChemoCentryx, Inc.(NasdaqGS:CCXI) dropped from S&P TMI Index
CI
10/24ChemoCentryx, Inc.(NasdaqGS:CCXI) dropped from S&P Biotechnology Select Industry Index
CI
SummaryQuotesChartsNewsRatingsCompanyFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Swissmedic OKs ChemoCentryx's Combo Therapy For Rare Blood Vessel Disease

09/27/2022 | 11:30pm EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA 2.05% 30.33 Delayed Quote.-47.99%
FRESENIUS SE & CO. KGAA -0.19% 26.51 Delayed Quote.-24.97%
VESSEL CO., LTD. 0.32% 6210 End-of-day quote.74.93%
VIFOR PHARMA AG -0.82% 169.05 Delayed Quote.5.05%
All news about CHEMOCENTRYX, INC.
10/24ChemoCentryx, Inc.(NasdaqGS:CCXI) dropped from S&P Global BM..
CI
10/24ChemoCentryx, Inc.(NasdaqGS:CCXI) dropped from S&P TMI Index
CI
10/24ChemoCentryx, Inc.(NasdaqGS:CCXI) dropped from S&P Biotechno..
CI
10/20Amgen Completes ChemoCentryx Acquisition
MT
10/20Chemocentryx, Inc. : Termination of a Material Definitive Agreement, Completion of Acquisi..
AQ
10/20Chemocentryx, Inc. Announces Executive Changes
CI
10/20Amgen successfully completes acquisition of chemocentryx
PR
10/20ChemoCentryx, Inc.(NasdaqGS:CCXI) dropped from NASDAQ Compos..
CI
10/20Amgen Inc. (NasdaqGS:AMGN) completed the acquisition of ChemoCentry..
CI
10/19ChemoCentryx, Inc.(NasdaqGS:CCXI) dropped from NASDAQ Biotec..
CI
More news
Analyst Recommendations on CHEMOCENTRYX, INC.
More recommendations
Chart CHEMOCENTRYX, INC.
Duration : Period :
ChemoCentryx, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Sangita Ghosh Senior Vice President-Technical Operations
Bill Slattery VP-Investor Relations & Corporate Communications
Kari E. Leetch Senior Vice President-Human Resources
Ching Yau Yi Chief Accounting Officer & Senior VP-Finance
Sector and Competitors